ISSN: 2157-7609
+44-77-2385-9429
S M Moghimi
Department of Pharmaceutics and Analytical Chemistry
University of Copenhagen, Denmark
Moein Moghimi is Professor of Nanomedicine and Head of the Nanomedicine Group at the Department of Pharmaceutics and Analytical Chemistry Faculty of Pharmaceutical Sciences, University of Copenhagen, Denmark. He further serves as the Director of the Centre for Pharmaceutical Nanotechnology and Nanotoxiocology CPNN and Group Leader in Pharmaceutical Nanotechnology at the NanoScience Center University of Copenhagen. He is also the Guest Professor of Nanomedicine at Multidisciplinary Research Center, Shantou University China and the elected Fellow of the Institute of Nanotechnology FIoN in UK. Previously he was Senior Lecturer in Biopharmacy and Molecular Pharmaceutics at the School of Pharmacy, University of Brighton UK, and The University Research Fellow in Advanced Drug Delivery Systems at the Department of Pharmaceutical Sciences, University of Nottingham UK. His research activities are focused on experimental nanomedicines, nanotoxicology and pharmaceutical nanotechnology.
He has pioneered research in design and surface engineering of nanoparticles and functional nanosystems for parenteral site-specific targeting and imaging modalities (e.g., splenotropic entities, lymphotropic agents, phagocyte-resistant nanoparticles and cancer nanomedicines) as well as the molecular basis of nanomaterial cytotoxicity (single cell studies) and adverse immunological reactions (complement activation mechanisms).